Jeff Johnson
Stock Analyst at Baird
(2.4)
# 683
Out of 5,291 analysts
156
Total ratings
58.51%
Success rate
25.38%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Cooper Companies | Maintains: Outperform | 117 107 | 83.87 | 27.58% | 16 | Mar 7, 2025 | |
Tandem Diabetes Care | Maintains: Neutral | 37 33 | 19.07 | 73.05% | 15 | Feb 27, 2025 | |
Alcon | Maintains: Outperform | 104 108 | 93.94 | 14.97% | 9 | Feb 27, 2025 | |
DexCom | Upgrades: Outperform | 86 104 | 67.64 | 53.76% | 13 | Jan 16, 2025 | |
Patterson Cos | Maintains: Neutral | 25 31 | 31.27 | -0.86% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 22 | 17.13 | 28.43% | 7 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 378 405 | 369.28 | 9.67% | 11 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 325 276 | 157.97 | 74.72% | 16 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 145 | 112.28 | 29.14% | 13 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 92 82 | 68.13 | 20.36% | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 180 238 | 259.93 | -8.44% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 70 | 37.83 | 85.04% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 53 61 | 17.47 | 249.17% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 67 | 14.95 | 348.16% | 6 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 | n/a | n/a | 7 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 178 | n/a | n/a | 6 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 31 | n/a | n/a | 3 | Nov 11, 2019 |